NCT06363812View on ClinicalTrials.gov

Probability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain Biology

CompletedOBSERVATIONAL

Enrollment

258

Participants

Timeline

Start Date

March 8, 2018

Primary Completion Date

May 15, 2021

Study Completion Date

December 31, 2024

Conditions

Breast Cancer

Trial Locations (1)

59100

Hospital of Prato, Prato

Sponsors

Collaborators (1)

Genomic Health®, Inc.

All Listed Sponsors

collaborator

Genomic Health®, Inc.

INDUSTRY

collaborator

Istituto Toscano Tumori

OTHER

lead

Fondazione Sandro Pitigliani

OTHER

NCT06363812 - Probability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain Biology | Biotech Hunter | Biotech Hunter